Orgenesis Inc banner

Orgenesis Inc
NASDAQ:ORGS

Watchlist Manager
Orgenesis Inc Logo
Orgenesis Inc
NASDAQ:ORGS
Watchlist
Price: 0.56 USD 0.9% Market Closed
Market Cap: $3.6m

Profitability Summary

Orgenesis Inc's profitability score is 32/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

32/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

32/100
Profitability
Score
32/100
Profitability
Score

Margins

Earnings Waterfall
Orgenesis Inc

Margins Comparison
Orgenesis Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Orgenesis Inc
NASDAQ:ORGS
3.6m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
407.9B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.9B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
178.6B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.4B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.4B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
70.5B AUD
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
37.8B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Orgenesis Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Orgenesis Inc
NASDAQ:ORGS
3.6m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
407.9B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
197.9B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
178.6B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.4B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.4B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
70.5B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
37.8B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Orgenesis Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett